Online inquiry

IVTScrip™ mRNA-Human ASPN, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25125MR)

This product GTTS-WK25125MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASPN protein. This product can be used in DCLK1+ progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001193335.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 54829
UniProt ID Q9BXN1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASPN, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25125MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK26808MR IVTScrip™ mRNA-Human ARHGEF11, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF11
GTTS-WK23254MR IVTScrip™ mRNA-Human ARMC3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARMC3
GTTS-WK16349MR IVTScrip™ mRNA-Human AMER3, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA AMER3
GTTS-WK27471MR IVTScrip™ mRNA-Human ARPC5, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARPC5
GTTS-WK23933MR IVTScrip™ mRNA-Human ASXL3, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ASXL3
GTTS-WK25709MR IVTScrip™ mRNA-Human ASF1B, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ASF1B
GTTS-WK11947MR IVTScrip™ mRNA-Human ADGRL3, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADGRL3
GTTS-WK16767MR IVTScrip™ mRNA-Human ANXA8L1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANXA8L1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →